BioForce Nanosciences Holdings, Inc.

What they do

The original nanotech subsidiary that made nano-particular measurement devices and molecular printers went bankrupt and its technology was sold to an unrelated third party. Current management entered the supplement business around 2015, private-labeling vitamins, minerals, powders and beverages, including the 'BioForce Eclipse' protein powder brand. In June 2026 the Company received assignment of federal oil and gas leases in Nye County, Nevada and changed its business model to oil and gas. It maintains an executive office in Virginia Beach, Virginia and uses office space owned by director/CFO Richard Kaiser's company, Yes International.

Revenue drivers

• BioForce Eclipse nutritional powder — Private-label supplement powder of amino acids, vitamins and plant-based proteins; the only named product line, historically sold via social media and telemarketing with no separately disclosed revenue.
• Planned retail and online supplement channels — Management describes intended sales through nutrition retailers, grocery, pharmacies and Amazon, plus gyms and health clubs, but reports no revenue from these channels.
• Nevada oil and gas leases — Eleven BLM leases covering approximately 19,957 acres in the White River Valley assigned June 5, 2026 and approved July 1, 2026; no production or revenue to date.

Recent performance

Annual revenue was $4,500 in 2017, $16,310 in 2018 and $17,775 in 2019, with the last reported quarterly revenue of $1 in the 2019-12-31 period. Net losses were $501,955 (2021), $485,514 (2022), $471,953 (2023), $490,437 (2024) and $1.3 million (2025); diluted EPS was negative $0.02 annually through 2024 and negative $0.04 in 2025. Operating cash flow has been negative every year shown: $77,772 (2021), $68,389 (2022), $46,702 (2023), $61,250 (2024) and $65,150 (2025). At June 30, 2026 the balance sheet showed total assets of $2.4 million, total liabilities of $84,767, shareholder equity of $2.3 million, and cash and equivalents of only $307.

Strategy

The stated mission is to become a provider of natural vitamins, minerals, supplements, powders and beverages, with plans for direct marketing, B2B sales, social media, trade shows and eventual national retail distribution. On June 5, 2026, citing intense competition in supplements, the Company changed its business model to oil and gas after being assigned Nevada federal leases controlled by majority shareholder Nexus Capital Investments. Planned lease development includes 3D seismic surveys, exploratory and development wells, completion and production testing, and gathering system construction. BioForce has not drilled any pilot wells and states no proven reserves have been established.

Risks

• No established oil and gas reserves or production — The Company states no proven reserves have been established and no pilot wells have been drilled on the Nevada Leases, so there is no assurance productive operations can be developed.
• Minimal liquidity — Cash and equivalents were only $307 at June 30, 2026, against a history of negative operating cash flow every year from 2021 through 2025.
• Related-party control and transactions — Majority shareholder Nexus Capital Investments sold the controlling stake, controls the lessor of the Nevada Leases, and the Company uses office space owned by its CFO/director Richard Kaiser.
• Small reporting company disclosure limits — The 10-K states the Company is a smaller reporting company not required to provide the information called for under Item 1A Risk Factors.

Outlook

Management intends to commence development activities on the Nevada Leases, including additional geological and geophysical studies and 3D seismic surveys, drilling of initial exploratory and development wells, completion and production testing, and construction of gathering systems and production infrastructure. The Company also states it plans to expand supplement marketing through direct marketing and B2B campaigns toward nationwide coverage. The leases have 10-year primary terms with automatic extensions for as long as oil or gas is produced in paying quantities, and a 12.5% federal royalty on gross production revenues would apply.